Keyword

magrolimab

Description: Magrolimab is a monoclonal antibody that targets CD47 and is investigated as an anticancer immunotherapy, particularly for blood cancers.
OpenAlex ID: keywords/magrolimab
2020 · Mark P. Chao, Chris H. Takimoto, et al. · Frontiers in Oncology · 273
2021 · Sabine Kayser, Mark J. Levis · British Journal of Haematology · 203
2022 · R. Maute, J. Xu, et al. · Immuno-Oncology Technology · 200
2020 · Naval Daver, Andrew H. Wei, et al. · Blood Cancer Journal · 181
2021 · Rosalynd Upton, Allison Banuelos, et al. · Proceedings of the National Academy of Sciences · 139
2020 · Caner Saygin, Hetty E. Carraway · Blood Reviews · 74
2024 · Valeria Santini, Maximilian Stahl, et al. · American Society of Clinical Oncology Educational Book · 69
2021 · Maria Teresa Voso, Giulia Falconi, et al. · Blood · 61
2022 · Max J. Gordon, Mitchell R. Smith, et al. · Blood Reviews · 59
2020 · George A. Fisher, Nehal J. Lakhani, et al. · Journal of Clinical Oncology · 56
Works count: 291
Citation count: 3,763
Year
Topic
Type